J07BN01 - Covid-19, RNA-Based Vaccine |
Probably Not Porphyrinogenic |
PNP |
Rationale
Based on the pharmacokinetics of the RNA-based covid-19 vaccine, no porphyrinogenic effects are expected.
Chemical description
mRNA-based vaccine.
Therapeutic characteristics
Indicated for preventing coronavirus disease 2019 (COVID-19) in individuals from the age of 6 months. It is administered by intramuscular injections.
Metabolism and pharmacokinetics
Vaccines are not metabolized by the cytochrome P450 system.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| Government bodies | ||
| 1. | European Medicines Agency (EMA). SmPC Comirnaty.
|
|
| 2. | Norwegian institute of public health. Vaccines and vaccination.
|
|
Tradenames
Comirnaty · Spikevax 
Comirnaty · Kostaive · mNEXSPIKE · Spikevax 
Comirnaty · Kostaive · mNexspike · Spikevax 
Comirnaty · Mnexspike · Spikevax 
Comirnaty · Kostaive · mNEXSPIKE · Spikevax 
Comirnaty · Mnexspike · Spikevax 
Comirnaty · Spikevax 
Comirnaty · Spikevax 
Comirnaty 
Comirnaty · mNEXSPIKE · Spikevax 
Comirnaty · Spikevax 
Comirnaty 
Comirnaty · Kostaive · mNEXSPIKE · Spikevax 
Comirnaty · Spikevax 
Comirnaty · Spikevax 
Comirnaty · Spikevax 
Comirnaty · Spikevax 
Bimervax · Comirnaty · Kostaive · mNEXSPIKE COVID · Nuvaxovid · Spikevax 
Comirnaty · Kostaive · mNEXSPIKE · Spikevax 
Comirnaty · mNEXSPIKE · Spikevax 
Comirnaty · Kostaive · mNEXSPIKE · Spikevax 
Comirnaty · Kostaive · mNexspike · Spikevax 
Comirnaty · Kostaive · Mnexspike · Spikevax 
Comirnaty · Kostaive · mNexspike · Spikevax 
Comirnaty · Spikevax 
Comirnaty · Kostaive · Mnexspike · Spikevax 
Vaccines